Blauvelt, A.; Strober, B.; Langley, R.; Kavanagh, S.; Arendt, C.; Boehnlein, M.; Lebwohl, M.; Reich, K. Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled 96-Week Data from Three Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1, CIMPASI-2 and CIMPACT). J of Skin 2019, 3, S39.